Mode
Text Size
Log in / Sign up
Phase 3 N=118 Randomized Triple-blind Treatment

Correction of Myopia Evaluation Trial 2

Myopia

Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Jun 2011
Primary outcome: Primary: Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years — 6; 3; 11; 8 participants

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Progressive Addition Lenses (PALs) (Device); Single Vision Lenses (SVLs) (Device)
Age
Pediatric · 8+ yrs
Sex
All
Sponsor
Jaeb Center for Health Research
Primary completion
Mar 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
6; 3; 11; 8; 16; 13
PRIMARY
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
-0.87; -1.15
SECONDARY
Distribution of Spherical Equivalent Refractive Error at 3 Years
0; 1; 2; 1; 18; 14
SECONDARY
Mean Spherical Equivalent Refractive Error at 3 Years
-2.41; -2.60
SECONDARY
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
8; 13; 13; 17; 15; 14
SECONDARY
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
-1.23; -1.39; -1.11; -1.14; -0.71; -1.19
SECONDARY
Mean Change in Spherical Equivalent Refractive Error From Baseline to 1 Year
-0.29; -0.42
SECONDARY
Mean Change in Spherical Equivalent Refractive Error From Baseline to 2 Years
-0.58; -0.80
SECONDARY
Excellent Spectacle Compliance
72; 90; 60; 76; 60; 71

Summary

The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.

Eligibility Criteria

Inclusion Criteria

  • Refractive error determined by cycloplegic autorefraction which meets all of the following:
  • Spherical equivalent: -0.50 to -3.00 D in both eyes
  • Astigmatism = 2.0 PD) present by alternate prism and cover test (APCT) at near using best refractive correction determined from non-cycloplegic subjective refraction

Exclusion Criteria

  • Strabismus present by cover-uncover test at far, near, and/or near with +2.00D over best subjective refraction
  • Current or prior use of PALs, bifocals, or contact lenses in either eye (prior or current use of SVLs is allowed)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00320593). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search